Glycosuria

1. SGLT2 inhibitors increase glycosuria in humans (69.4% vs. 39.9%).

   “Glycosuria was more frequent among users than nonusers (69.4% vs. 39.9%; OR = 3.43; 95% CI, 2.02-5.82; p p = 0.110).”

   Humansat least three months

   Association of SGLT2 Inhibitor Use with Glycosuria, Pyuria, Urinary Symptoms, and Significant Urine Culture Positivity in Adults with Type 2 Diabetes: A Prospective Cross-Sectional Study · Medicina (Kaunas, Lithuania) · 7 Sep 2026

SGLT2 inhibitors →

1. HbA1c is associated with glycosuria in humans.

   “higher HbA1c levels were independently associated with glycosuria.”

   Humansin adults with type 2 diabetes

   Association of SGLT2 Inhibitor Use with Glycosuria, Pyuria, Urinary Symptoms, and Significant Urine Culture Positivity in Adults with Type 2 Diabetes: A Prospective Cross-Sectional Study · Medicina (Kaunas, Lithuania) · 7 Sep 2026

HbA1c →